National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 5 of 1990) (Cth)

COMMONWEALTH OF AUSTRALIA

NATIONAL HEALTH ACT 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUB-SECTION 85(2AA)

No. PB5 of 1990

I, MARGARET NONA FORD, Principal Advisor, Health Care Access Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

1.        This Declaration shall come into operation on 1 August 1990.

2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Ampicillin Trihydrate with Purified Water B.P.

Chloral Hydrate

Chlorpromazine

Clopamide

Diloxanide Furoate

Fenoterol Hydrobromide

Lindane

“Locasol New Formula”

Primaquine Phosphate

Sulphafurazole

Testosterone Propionate

Tetracycline Hydrochloride with a buffering agent and Nystatin

Tetracycline Hydrochloride with Nystatin

Thiopropazate Hydrochloride

Dated this twenty-fifth day of July 1990.

MARGARET FORD

PRINCIPAL ADVISOR

HEALTH CARE ACCESS DIVISION

DEPARTMENT OF COMMUNITY SERVICES AND HEALTH

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH